PSUSA/00000772/202404
Submitted by Anonymous (not verified) on 4 December 2024 - 12:31
PSUSA/00000772/202404
Bimervax: Periodic safety update report assessment 30 March 2023 to 29 September 2023
Submitted by Anonymous (not verified) on 4 December 2024 - 12:02
Bimervax: Periodic safety update report assessment 30 March 2023 to 29 September 2023
EVVet3 EVWeb Production - Release notes
Submitted by Anonymous (not verified) on 4 December 2024 - 11:30
EVVet3 EVWeb Production - Release notes
Record of data processing activity relating to Security Access Control System
Submitted by Anonymous (not verified) on 4 December 2024 - 11:20
Record of data processing activity relating to Security Access Control System
European Medicines Agency’s data protection notice for the operation of the Security Access Control System
Submitted by Anonymous (not verified) on 4 December 2024 - 11:18
European Medicines Agency’s data protection notice for the operation of the Security Access Control System
Agenda - Medicine Shortages (SPOC) Working Party 5 December 2024
Submitted by Anonymous (not verified) on 4 December 2024 - 10:51
Agenda - Medicine Shortages (SPOC) Working Party 5 December 2024
Clinical requirements for non replacement therapy in haemophilia A and B - Scientific guideline
Submitted by Anonymous (not verified) on 4 December 2024 - 10:40
Clinical requirements for non replacement therapy in haemophilia A and B - Scientific guideline
Medicine shortage mitigation plan - template
Submitted by Anonymous (not verified) on 4 December 2024 - 10:35
Medicine shortage mitigation plan - template
Medicine shortage prevention plan - template
Submitted by Anonymous (not verified) on 4 December 2024 - 10:34
Medicine shortage prevention plan - template
Scintimun-H-C-PSUSA-00000385-202401 : EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation
Submitted by Anonymous (not verified) on 4 December 2024 - 10:08
Scintimun-H-C-PSUSA-00000385-202401 : EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation